Farshid Dayyani, MD, PhD of UC Irvine Health discusses the BRAF trial and explains how to overcome resistance to anti-EGFR therapy in patients with metastatic colorectal cancer. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Overcoming Resistance to Anti-EGFR Therapy in Patients with Metastatic Colorectal Carcinoma
